{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:03:54Z","timestamp":1793754234464,"version":"4.6.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The link between thyroid function and insulin resistance and metabolic dysfunction-associated fatty liver disease (MASLD) is becoming increasingly recognized. The primary goal of this study was to investigate the relationship between free triiodothyronine (FT3) levels, the triglyceride-glucose index (TyG) index, and the likelihood of MASLD in euthyroid individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional analysis of 18,298 euthyroid individuals was conducted, comparing 6,144 with MASLD to 12,154 controls. The study evaluated indicators related to clinical, metabolic, and thyroid function. The combined effect of the FT3 and TyG index on the likelihood of MASLD was assessed using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MASLD group presented with higher male prevalence, older age, and increased rates of hypertension and diabetes. Significant correlations were observed between FT3, TyG, and metabolic parameters. After controlling for potential confounders, FT3 remained significantly associated with increased MASLD risk (adjusted OR = 1.35, 95% CI: 1.23-1.49; <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Similarly, the TyG index was independently associated with higher MASLD risk (adjusted OR = 3.99, 95% CI: 3.40-4.68; <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The high FT3 (\u2265 4.98 pmol\/L)\/high TyG (\u2265 8.55) group exhibited significantly elevated MASLD risk compared to the low FT3\/low TyG group (OR = 5.38, 95% CI: 4.62-6.26; <jats:italic>P<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elevated FT3 and TyG index are independently associated with an increased risk of MASLD, and they exhibit a significant synergistic additive interaction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1526198","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:10:59Z","timestamp":1745467859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Free triiodothyronine and triglyceride-glucose index interaction on metabolic dysfunction-associated steatotic liver disease risk in euthyroid individuals"],"prefix":"10.3389","volume":"16","author":[{"given":"Lei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinghuang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and Malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32774","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","volume":"77","author":"Yip","year":"2023","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133649","article-title":"The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications","volume":"11","author":"Palma","year":"2022","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2022.159209","article-title":"Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis","volume":"1867","author":"Hughey","year":"2022","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1617805","article-title":"Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911689","article-title":"Current research on the pathogenesis of NAFLD\/NASH and the gut\u2013liver axis: gut microbiota, dysbiosis, and leaky-gut syndrome","volume":"23","author":"Kobayashi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31296","article-title":"Thyroid hormone signaling and the liver","volume":"72","author":"Ritter","year":"2020","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/152850","article-title":"Why can insulin resistance be a natural consequence of thyroid dysfunction","volume":"2011","author":"Brenta","year":"2011","journal-title":"J Thyroid Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4158\/EP.15.3.254","article-title":"Excess thyroid hormone and carbohydrate metabolism","volume":"15","author":"Potenza","year":"2009","journal-title":"Endocr Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18584","article-title":"Thyroid hormone excess and glucose intolerance","volume":"109","author":"Dimitriadis","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332491","article-title":"Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis","volume":"73","author":"Mantovani","year":"2024","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12020-010-9408-3","article-title":"Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes","volume":"39","author":"Lambadiari","year":"2011","journal-title":"Endocrine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e328355cd6c","article-title":"Thyroid hormone and obesity","volume":"19","author":"Pearce","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820917869","article-title":"The role of thyroid hormone in metabolism and metabolic syndrome","volume":"11","author":"Teixeira P de F dos","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study","volume":"101","author":"Bano","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.metabol.2016.11.002","article-title":"Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study","volume":"67","author":"van den Berg","year":"2017","journal-title":"Metabolism"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.3136","article-title":"Thyroid function and risk of non-alcoholic fatty liver disease in euthyroid subjects","volume":"17","author":"Liu","year":"2018","journal-title":"Ann Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20470","DOI":"10.1038\/s41598-023-47269-4","article-title":"Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population","volume":"13","author":"Zeng","year":"2023","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","article-title":"Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome","volume":"32","author":"Son","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B24","article-title":"_jstable: Create Tables from Different Types of Regression_","author":"Kim","year":"2024"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.simpa.2021.100147","article-title":"InteractionR: An R package for full reporting of effect modification and interaction","volume":"10","author":"Alli","year":"2021","journal-title":"Softw Impacts"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00139-9","article-title":"Recommendations for accurate reporting in medical research statistics","volume":"403","author":"Mansournia","year":"2024","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-5573-3-5","article-title":"Measuring additive interaction using odds ratios","volume":"3","author":"Kalilani","year":"2006","journal-title":"Epidemiol Perspect Innov"},{"key":"B28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/0003-4819-139-3-200308050-00010","article-title":"The thermogenic effect of thyroid hormone and its clinical implications","volume":"139","author":"Silva","year":"2003","journal-title":"Ann Intern Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1172\/JCI112798","article-title":"Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue","volume":"79","author":"Bianco","year":"1987","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201X.2005.01463.x","article-title":"Thyroid hormones as molecular determinants of thermogenesis","volume":"184","author":"Silvestri","year":"2005","journal-title":"Acta Physiol Scand"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.766419","article-title":"Sensitivity to thyroid hormone indices are closely associated with NAFLD","volume":"12","author":"Lai","year":"2021","journal-title":"Front Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad186","article-title":"Central sensitivity to free triiodothyronine with MAFLD and its progression to liver fibrosis in euthyroid adults","volume":"108","author":"Wan","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S433493","article-title":"Stronger associations of tyG index with diabetes than tyG-obesity-related parameters: more pronounced in young, middle-aged, and women","volume":"16","author":"Xing","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58070876","article-title":"TyG index performs better than HOMA-IR in Chinese type 2 diabetes mellitus with a BMI < 35 kg\/m2: A hyperglycemic clamp validated study","volume":"58","author":"Luo","year":"2022","journal-title":"Medicina (Mex)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13098-023-01181-z","article-title":"Association of triglyceride-glucose index with cardiovascular disease among a general population: a prospective cohort study","volume":"15","author":"Wan","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12933-023-02089-8","article-title":"Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population","volume":"23","author":"Guo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Lett"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1526198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:11:01Z","timestamp":1745467861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1526198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":38,"alternative-id":["10.3389\/fendo.2025.1526198"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1526198","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1526198"}}